131 related articles for article (PubMed ID: 28732437)
1. Effect of MicroRNA-21 Transfection on In-vitro Differentiation of Human Naive CD4+ T Cells to Regulatory T Cells.
Namdari H; Ghayedi M; Hadjati J; Rezaei F; Kalantar K; Rahimzadeh P; Salehi E
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):235-244. PubMed ID: 28732437
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta/atRA-induced Tregs express a selected set of microRNAs involved in the repression of transcripts related to Th17 differentiation.
Schiavinato JLDS; Haddad R; Saldanha-Araujo F; Baiochi J; Araujo AG; Santos Scheucher P; Covas DT; Zago MA; Panepucci RA
Sci Rep; 2017 Jun; 7(1):3627. PubMed ID: 28620241
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑30a controls the instability of inducible CD4+ Tregs through SOCS1.
Zhou Y; Li Y; Lu J; Hong X; Xu L
Mol Med Rep; 2019 Nov; 20(5):4303-4314. PubMed ID: 31545427
[TBL] [Abstract][Full Text] [Related]
5. A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the
Zhang Y; Liu W; Chen Y; Liu J; Wu K; Su L; Zhang W; Jiang Y; Zhang X; Zhang Y; Liu C; Tao L; Liu B; Zhang H
J Immunol; 2018 Feb; 200(3):1053-1063. PubMed ID: 29282311
[TBL] [Abstract][Full Text] [Related]
6. MiR-568 inhibits the activation and function of CD4⁺ T cells and Treg cells by targeting NFAT5.
Li W; Kong LB; Li JT; Guo ZY; Xue Q; Yang T; Meng YL; Jin BQ; Wen WH; Yang AG
Int Immunol; 2014 May; 26(5):269-81. PubMed ID: 24355664
[TBL] [Abstract][Full Text] [Related]
7. Natural and inducible Tregs in swine: Helios expression and functional properties.
Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G Enhances Generation of Inducible T Regulatory Cells and Increases Their Regulatory Function.
Okuda S; Kamei S; Sasaki T
Biol Pharm Bull; 2018; 41(12):1830-1836. PubMed ID: 30504684
[TBL] [Abstract][Full Text] [Related]
9. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.
Hoechst B; Gamrekelashvili J; Manns MP; Greten TF; Korangy F
Blood; 2011 Jun; 117(24):6532-41. PubMed ID: 21493801
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.
Lei J; Hasegawa H; Matsumoto T; Yasukawa M
J Immunol; 2010 Dec; 185(12):7186-98. PubMed ID: 21057085
[TBL] [Abstract][Full Text] [Related]
12. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
[TBL] [Abstract][Full Text] [Related]
13. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells.
So T; Croft M
J Immunol; 2007 Aug; 179(3):1427-30. PubMed ID: 17641007
[TBL] [Abstract][Full Text] [Related]
15. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.
Zheng SG; Wang J; Wang P; Gray JD; Horwitz DA
J Immunol; 2007 Feb; 178(4):2018-27. PubMed ID: 17277105
[TBL] [Abstract][Full Text] [Related]
16. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
[TBL] [Abstract][Full Text] [Related]
17. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.
Zheng SG; Gray JD; Ohtsuka K; Yamagiwa S; Horwitz DA
J Immunol; 2002 Oct; 169(8):4183-9. PubMed ID: 12370347
[TBL] [Abstract][Full Text] [Related]
18. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6.
Zheng SG; Wang J; Horwitz DA
J Immunol; 2008 Jun; 180(11):7112-6. PubMed ID: 18490709
[TBL] [Abstract][Full Text] [Related]
20. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}.
Rao PE; Petrone AL; Ponath PD
J Immunol; 2005 Feb; 174(3):1446-55. PubMed ID: 15661903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
